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RESEARCH ARTICLE
The conserved metalloprotease invadolysin is present in
invertebrate haemolymph and vertebrate blood
Kanishk Abhinav1, Linda Feng1, Emma Morrison1, Yunshin Jung2, James Dear1, Satoru Takahashi2 and
Margarete M. S. Heck1,*
ABSTRACT
We identified invadolysin, a novel essential metalloprotease, for
functions in chromosome structure, cell proliferation and migration.
Invadolysin also plays an important metabolic role in insulin signalling
and is the only protease known to localise to lipid droplets, the main
lipid storage organelle in the cell. In silico examination of the protein
sequence of invadolysin predicts not only protease and lipase
catalytic motifs, but also post-translational modifications and the
secretion of invadolysin. Here we show that the protease motif of
invadolysin is important for its role in lipid accumulation, but not in
glycogen accumulation. The lipase motif does not appear to be
functionally important for the accumulation of lipids or glycogen. Post-
translational modifications likely contribute to modulating the level,
localisation or activity of invadolysin. We identified a secreted form of
invadolysin in the soluble fraction of invertebrate hemolymph (where
we observe sexually dimorphic forms) and also vertebrate plasma,
including in the extracellular vesicle fraction. Biochemical analysis for
various post-translational modifications demonstrated that secreted
invadolysin is both N- and O-glycosylated, but not apparently
GPI-linked. The discovery of invadolysin in the extracellular milieu
suggests a role for invadolysin in normal organismal physiology.
KEY WORDS: Invadolysin, Protease, Metalloprotease, Plasma,
Hemolymph
INTRODUCTION
Proteases perform a wide array of functions in normal physiology
ranging from cell proliferation, differentiation and death to
digestion, blood coagulation and complement pathway activation
(Lecker et al., 2006; Vandenabeele et al., 2005; Walsh and Ahmad,
2002; Werb et al., 1999). In silico analyses of metazoan genomes
have identified more than 500 proteases and inhibitors accounting
for approximately 2–5% of total gene number (Puente et al., 2003;
Turk, 2006). With such a high percentage of the genome dedicated
to protein turnover, it is somewhat surprising that to date, only a
small fraction of these enzymes have been thoroughly investigated.
Therefore, the characterisation of novel proteases is an important
area of investigation, improving our understanding of the role of
proteases in normal physiology and disease pathophysiology.
The ability to perform a wide variety of functions, coupled with
the modulation of enzymatic activity, make proteases attractive drug
targets. ACE (angiotensin-converting enzyme) inhibitors are widely
used for treating hypertension, myocardial infarction and renal
failure (Wong et al., 2004). HIV (human immunodeficiency virus)
protease inhibitors have been successfully used to treat HIV-
infected patients (Flexner, 1998). On the other hand, development
of MMP inhibitors for treatment of connective tissue diseases failed
during clinical trials, due largely to off-target effects (Cathcart and
Cao, 2015). These results further signify the importance of a more
thorough investigation of proteases and their activities to improve
the development of protease-based therapies.
Invadolysin plays an important role in the cell cycle, cell
migration and the maintenance of normal chromosome structure.
Crucially, the gene is essential for life in Drosophila and plays
analogous roles in zebrafish (McHugh et al., 2004; Rao et al., 2015;
Vass and Heck, 2013). Invadolysin has a conserved metalloprotease
motif (HEXXH) and is the only member of the single-gene M8
family of metalloproteases in metazoa (McHugh et al., 2004) – the
prototype of this family being the leishmanolysin/GP63 protease
from Leishmania. To date, invadolysin is the only protease shown to
localise to lipid droplets, the primary lipid storage organelle of the
cell (Cobbe et al., 2009). More recent studies have identified key
roles for invadolysin in metabolism including insulin signalling,
lipid accumulation and the maintenance of normal mitochondrial
function (Chang et al., 2016; Di Cara et al., 2013). Though a fairly
conserved lipase motif lies downstream of the highly conserved
protease motif, neither of these motifs has been thoroughly
examined in invadolysin’s function. Are the protease and lipase
motifs functional and do they contribute to invadolysin’s activity?
Protease activity may be regulated by various strategies such as
irreversible activation of an inactive zymogen, reversible binding of
cofactors, or exposure to different intra- or extra-cellular milieus
(Twining, 1994). Physical subcellular compartmentalisation is also
utilised to regulate protease activity (Brix et al., 2013). Proteases
may exist in soluble intracellular, membrane-bound, or extracellular
forms. As proteases generally have numerous substrates, regulating
substrate localization or accessibility will also serve to modulate
activity (Schauperl et al., 2015). Furthermore, post-translational
modifications such as phosphorylation, N- or O-linked
glycosylation or GPI-anchor addition may not only affect protein
structure and stability, but also impact on substrate interaction and
binding affinity (Goettig, 2016). All these factors further add to the
complexity of the mechanisms regulating protease activity. In
this study, we address the biosynthesis and post-translational
modification of invadolysin.
The first evidence for a diffusible protease was demonstrated
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(Gross and Lapiere, 1962). A number of extracellular proteases have
been discovered since. Proteases such as chymotrypsin, trypsin
and carboxypeptidase (components of the digestive system) are
responsible for hydrolysing proteins before absorption in the
gastrointestinal tract (Szmola et al., 2011). Extracellular proteases
play important roles in angiogenesis, tissue remodelling and wound
healing (Birkedal-Hansen et al., 1993; Verma and Hansch, 2007).
The ADAMTSs (a disintegrin and metalloproteinase with
thrombospondin motifs) family of extracellular metalloproteases
are important for angiogenesis (Rodríguez-Manzaneque et al.,
2015), whereas secreted metalloproteases such as MMPs (matrix
metalloproteinase) play vital roles in extracellular matrix
remodelling (Birkedal-Hansen et al., 1993). ADAMTSs and
MMPs, each represented by complex multi-gene families, are
some of the better-characterised secreted proteases. However,
functional redundancy of other family members often complicates
interpretation of phenotypic disruption.
We previously demonstrated that invadolysin plays a crucial role
in metabolism and energy storage in Drosophila (Chang et al.,
2016; Cobbe et al., 2009). We set about further examining these
functions using a number of approaches. We generated transgenic
fly lines that expressed either wild-type, protease- or lipase-dead
forms of invadolysin and compared lipid and glycogen
accumulation amongst them. In silico analysis of the invadolysin
sequence identified potential sites of post-translational
modifications, which suggested not only phosphorylation,
glycosylation and GPI-anchor addition, but also the secretion of
invadolysin. This led to our discovery of invadolysin in the soluble
fraction of both vertebrate blood and invertebrate hemolymph.
While secreted invadolysin is glycosylated, it does not appear to
have a GPI-anchor. A portion of this secreted invadolysin is present
in a human plasma fraction enriched for extracellular vesicles,
suggesting additional roles in mediating communication between
cells or tissues. Our present study opens new avenues of research
into the physiological role(s) of extracellular invadolysin.
RESULTS
In silico identification of conserved sequence features of
invadolysin
Metalloproteases are generally zinc-dependent enzymes that
have a conserved HEXXH (zincin) or HXXEH (inverzincin)
metalloprotease motif (Gomis-Rüth, 2003). In addition to having
the classical HEXXH zincin metalloprotease motif, invadolysin
also has a third conserved histidine residue and a downstream Met-
turn (Fig. 1, red and green), placing invadolysin in theM8 subfamily
of metalloproteases (McHugh et al., 2004). Leishmanolysin/GP63,
a major surface protease of Leishmania major (though also
found intra- and extra-cellularly), is the prototype for the M8
leishmanolysin subfamily of metalloproteases (Gomis-Rüth, 2003;
McGwire et al., 2002). Invadolysin additionally has a conserved
lipase (GXSXG) motif just downstream of the protease motif
(Fig. 1, purple). The lipase motif consists of two glycines and a
serine where the serine is the catalytically-active residue (Wong and
Schotz, 2002).
Human invadolysin is represented by four different variants – two
for each of two different N-terminal variants that vary by alternative
splicing of a 37 amino acid exon (between yellow arrowheads).
Invadolysin variant 1 is predicted to encode an N-terminal signal
sequence when analysed by SignalP 4.1 (a signal sequence
prediction server) (Fig. 1, light blue) (Nielsen et al., 1997;
Petersen et al., 2011). Variant 2 (not found in mouse or fly) is not
predicted to encode an N-terminal signal sequence. Synthesis of
variant 2 is dependent on the use of an alternative translation start
site (Cobbe et al., 2009). Though variant 2 can be detected by RT-
PCR, it is not as prevalent as variant 1, and under what conditions it
is translated is currently under investigation. We have identified
the expression of variant 2 during the later stages of in vitro
adipogenesis (Chang et al., 2016). In silico analysis of invadolysin
open reading frames from different species thus suggests the
presence of a signal sequence that could target the translation of
invadolysin to the secretory pathway.
The classical or conventional pathway of protein secretion utilises
an N-terminal signal sequence to target the nascent protein to the
endoplasmic reticulum and subsequently to the Golgi apparatus
(Lippincott-Schwartz et al., 2000). The protein may then translocate
from the Golgi apparatus to the cell surface or be secreted via
extracellular vesicles (Bendtsen et al., 2004; Lippincott-Schwartz
et al., 2000). Proteins frequently undergo assorted post-translational
modifications during their transport within the secretory pathway.
N-glycosylation and C-terminal GPI-anchor addition occur within
the endoplasmic reticulum (Aebi, 2013; Eisenhaber et al., 2001),
while O-glycosylation occurs in the Golgi apparatus (Spiro, 2002).
Big-PI Predictor (Eisenhaber et al., 1999) predicted the presence of
a GPI-anchor site near the C-terminus of invadolysin (Fig. 1, dark
blue). A GPI-addition could anchor invadolysin to the plasma
membrane (Fujita and Kinoshita, 2012; Orlean and Menon, 2007).
The presence of several N-glycosylation (orange) and O-
glycosylation (turquoise) sites are also predicted for invadolysin
(NetNGlyc 1.0, Gupta and Brunak, 2002; and NetOGlyc 3.1,
Steentoft et al., 2013, respectively). Biochemical analysis of these
predicted motifs in invadolysin is addressed below.
As highlighted in our identification of invadolysin (McHugh
et al., 2004), the higher eukaryotic forms of invadolysin all contain
distinct regions of sequence that are not present in leishmanolysin
(Fig. 1, visible as gaps in the bottom row of the alignment). In spite
of this, nine pairs of cysteines are conserved in spacing and position
(Fig. 1, grey), suggesting that the structural ‘core’ of invadolysin
may resemble that of leishmanolysin. The numbered black circles
represent which cysteines are disulphide-bonded with one another
within the leishmanolysin crystal structure (Schlagenhauf et al.,
1998).
Proteolytic activity of invadolysin is important for its role in
lipid accumulation
Our previous studies suggested a crucial role for invadolysin in
energy storage. invadolysin mutant third instar larvae have reduced
fat body thickness and cellular cross-sectional area (Cobbe et al.,
2009). Critically, invadolysin mutants also have reduced
triglyceride and glycogen levels (Chang et al., 2016; McHugh
et al., 2004). To further analyse the role of invadolysin’s conserved
protease and lipase catalytic motifs in lipid and glycogen storage,
transgenic Drosophila strains with mutated motifs were generated
by site-directed mutagenesis. A protease dead (E258A) form of
invadolysin was generated by mutating the glutamic acid residue
within the protease motif, whilst a lipase dead (S266A) form was
generated by mutating the serine residue within the lipase motif
(Fig. 2A). Mutant versions of invadolysin were placed under the
control of a UAS promoter (Brand and Perrimon, 1993).
invadolysin transgenes were integrated into a predetermined
location within the genome (in this case, on the second
chromosome) using the phiC31 integration system (Bischof et al.,
2007). This system was exploited to minimise chromosomal
positional effect on transgene expression which might affect
levels or catalytic activity of the various invadolysin transgenes
2
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Fig. 1. See next page for legend.
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(Markstein et al., 2008). invadolysin transgene expression was
verified by RT-PCR using primers (diagrammed in Fig. 2B) that
selectively amplified the transgenic mRNA (Fig. 2C, top panel).
The PCR amplicons were subsequently sequenced to confirm the
presence of the desired E258A and S266A mutations in the
invadolysin transgenic mRNAs (Fig. 2D).
Using the UAS-Gal4 system, we examined transgenic flies
overexpressing wild-type or mutant forms of invadolysin for
triglyceride and glycogen levels. A tubulin-Gal4 driver was utilised
to generate ubiquitous expression. Flies overexpressing wild-type
invadolysin accumulated significantly higher levels of triglyceride
compared to control animals (Fig. 2E). Flies overexpressing the
lipase-dead form of invadolysin also accumulated higher levels
of triglyceride, suggesting that this motif was not essential to
accumulate increased triglyceride. On the other hand, the ability of
flies to accumulate higher amounts of triglyceride was impaired
upon overexpression of a protease-dead form of invadolysin. These
data suggest intriguingly that invadolysin’s proteolytic activity is
important for its role in lipid accumulation. Overexpression of any of
the three invadolysin transgenes had no significant effect on
glycogen accumulation (Fig. 2F). We propose that the decreased
glycogen level observed in invadolysin mutants is likely due to
impaired insulin signalling or metabolism of glycogen reserves
(Chang et al., 2016). Immunoblotting of ovaries from wild type, a
Da-Gal4 driver, and the three invadolysin transgenes suggests that
invadolysin is overexpressed perhaps three- to fivefold in the
transgenic lines compared to the wild type, and Da-Gal4 driver
alone controls (data not shown).
An extracellular form of invadolysin is present in Drosophila
hemolymph
To examine if the predicted signal sequence in invadolysin led to
secretion of the protein, Drosophila hemolymph was analysed
by immunoblotting. Hemolymph is the invertebrate functional
equivalent of vertebrate blood, and like blood in a vertebrate, is
composed of a cellular component and soluble plasma (Wyatt et al.,
1956). The cellular component is comprised of haemocytes, which
include crystal cells, plasmatocytes, lamellocytes and precursor cells
(Kurucz et al., 2007). Immunoblotting of whole and fractionated
hemolymph from adult male and female Drosophila identified that
invadolysin was indeed present in soluble plasma, but intriguingly,
that extracellular invadolysin differs in male (111 kDa) and female
(46 kDa) flies (Fig. 3B,C). We therefore examined male and female
gonads by immunoblotting and observed that invadolysin similar in
molecular weight to the secreted forms was present in testes and
ovaries (Fig. 3D,E). These results suggest testes and ovaries could be
a source of secreted invadolysin, or alternatively, that these tissues
import invadolysin from hemolymph.
As discussed previously, proteins encoding a signal sequence are
targeted to the endoplasmic reticulum and subsequently to the Golgi
apparatus and secretory vesicles (Bendtsen et al., 2004). Several
drugs can inhibit protein secretion by blocking the transport of
vesicles along the secretory pathway. Brefeldin A disrupts protein
transport from the endoplasmic reticulum to the Golgi apparatus by
dissociating peripheral Golgi associated proteins. Monensin is a
Na+ ionophore that disrupts transport within the Golgi apparatus
(Helms and Rothman, 1992; Mollenhauer et al., 1990).
Tunicamycin inhibits N-glycosylation in the endoplasmic
reticulum inducing endoplasmic reticulum stress which in turn
inhibits protein secretion (Iwata et al., 2016). Feeding Drosophila a
cocktail of Brefeldin A/Monensin or Tunicamycin decreased the
level of invadolysin in male plasma (Fig. 3F). On the other hand,
treatment with the protein transport inhibitors resulted in no change
in the levels of invadolysin in female plasma (Fig. 3G). This result
suggests that different mechanisms are responsible for the
deposition of invadolysin in male versus female hemolymph. In
addition, the 46 kDa female form of invadolysin may have a longer
half-life than the 111 kDa form observed in males.
Invadolysin is a component of vertebrate blood
We aimed to determinewhether invadolysin was also extracellularly
present in higher eukaryotes. Fractionated mouse blood was
analysed for the presence of invadolysin. Two different
invadolysin antibodies, R2192 and G6456, raised against different
epitopes of the protein (Fig. 4A) detected an extracellular form of
invadolysin (Fig. 4B,C). A 53 kDa form of invadolysin was
detected in whole mouse blood, and also serum and plasma
fractions. The R2192 antibody further detected a 66 kDa form of
invadolysin enriched in the blood cell fraction (Fig. 4B). An
extracellular form of invadolysin at a similar molecular weight of
51–53 kDa was also detected in two samples each of rat and pig
plasma (Fig. 4D,E).
Immunoblotting of human plasma with two antibodies
recognising distinct epitopes of invadolysin separated by 408
amino acids, G3646 and G6456, detected invadolysin at∼51 kDa in
six control samples (Fig. 4F,G). This band was less readily detected
with the G6456 antibody which may be due to the proximity of
albumin and immunoglobulin heavy chain, accounting for 70–80%
of the total protein content of plasma (Liu et al., 2011; Steel et al.,
2003). To improve the detection of invadolysin, abundant plasma
proteins were removed using a commercially-available abundant
plasma protein removal kit (see Materials and Methods).
Immunoblotting of human plasma by G6456 after depletion of
the 12 most abundant proteins dramatically improved detection of
invadolysin as evidenced by increased intensity and resolution of
invadolysin (Fig. 4H). After depletion of the abundant proteins from
plasma, invadolysin appears to migrate at 58 kDa rather than
∼51 kDa in whole plasma. This result corroborates the suggested
impact on the migration of invadolysin by abundant plasma proteins
in the 50–70 kDa molecular weight range. Most importantly, these
results demonstrate that deposition of invadolysin into an
organism’s circulation is conserved amongst higher eukaryotes.
We have tested more than 40 mouse, and more than 20 human
samples (both male and female from different ages) and observed
Fig. 1. Multiple sequence alignment of invadolysin protein sequence
from Homo sapiens (Hs.v2: variant with an alternative start site; Hs.v1:
the more abundant invadolysin variant), Mus musculus (Mm),
Drosophila melanogaster (Dm) with Gp63 (leishmanolysin) using
ClustalX. The schematic was generated using Jalview to highlight sequence
features within the protein. Signal sequence was predicted using SignalP 4.1
Server (light blue), O-glycosylation sites were predicted using NetOGlyc 4.0
Server - DTU CBS (turquoise), N-glycosylation was predicted using
NetNGlyc 1.0 Server - DTU CBS (orange) and GPI-anchor addition was
predicted using big-PI Predictor (darker blue). The conserved
metalloprotease motif and the third histidine residue are highlighted in red
and the downstream Met-turn is highlighted in green. The conserved
metalloprotease motif, third histidine and the downstream Met-turn are the
key identifying features of metalloprotease that places invadolysin in the
leishmanolysin M8 subclass of metalloprotease. Adjacent to the conserved
metalloprotease motif in invadolysin is a fairly conserved lipase motif
(purple). Cysteine residues conserved between invadolysin and
leishmanolysin are highlighted in grey and those that have been identified to
form disulphide bonds in leishmanolysin have been numbered
(Schlagenhauf et al., 1998). An alternatively spliced 37 amino acid exon
(in human) is between the two yellow arrowheads.
4









 by guest on March 19, 2020http://bio.biologists.org/Downloaded from 
Fig. 2. See next page for legend.
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consistent results – that is, no obvious differences at the level of
whole serum or plasma samples.
Extracellular invadolysin is glycosylated and present in the
extracellular vesicular fraction
To simplify the composition of the plasma fraction containing
invadolysin, we set about developing a biochemical enrichment for
invadolysin. Polyethylene glycol has been used to enrich a
particular fraction from a complex protein mixture such as serum
or plasma (Haskó et al., 1982). Precipitation of human plasma with
different concentrations of PEG (4–10%) clearly shows that
invadolysin can be enriched in the PEG-pellet with relatively low
concentrations (Fig. 5A). We anticipate that the polyethylene glycol
precipitation procedure developed in this study will facilitate
subsequent detailed analyses of invadolysin structure and function
in vertebrates.
Human plasma invadolysin in the 8% PEG supernatant and pellet
and fractions was analysed for N- and O-linked glycosylation, as well
as for GPI-anchor addition, following enzymatic treatment and
immunoblotting for shifts in electrophoretic migration. PNGase F
removesN-linked glycosylation, andO-Glycosidase removesO-linked
glycosylation (Magnelli et al., 2011), while PI-PLC is used to remove
GPI-anchors (Lehto and Sharom, 2002). While neither calf intestinal
phosphatase (CIP) nor PI-PLC treatment resulted in a change to the
migration of invadolysin, a faster electrophoretic migration was
observed following treatment of both supernatant and pellet fractions
with PNGase F and O-Glycosidase (Fig. 5B,C). The prominent bands
at ∼35 and ∼150 kDa in the PNGase F and O-Glycosidase lanes
represent the added enzymes, respectively (red asterisks). These results
demonstrate that invadolysin in human plasma is N- and
O-glycosylated, but not GPI-anchored.
Plasma, as the soluble component of blood, is a complex fraction
including numerous different vesicular fractions such as exosomes,
microvesicles, membrane particles and apoptotic bodies (EL
Andaloussi et al., 2013). Exosomes are cell-derived vesicles that
play a vital role in intercellular signalling (Théry et al., 2002). We
analysed human plasma fractions enriched for extracellular vesicles
for the presence of invadolysin. In this fractionation, the extracellular
vesicle fraction contains both exosomes and microvesicles.
Purification of this compartment was verified by the presence of
flotillin I (Fig. 6A). Immunoblotting for invadolysin with the non-
overlappingG3646 andG6456 antibodies demonstrated invadolysin
to be present in all plasma fractions analysed (Fig. 6B,C). However, a
strong signal for invadolysin in the plasma fraction enriched for
extracellular vesicles suggests invadolysin may play a role in
extracellular vesicle biology.
DISCUSSION
The results presented herein are focused on the catalytic motifs and
biosynthesis of the conserved metalloprotease invadolysin.
Invadolysin has a metalloprotease motif, a third histidine residue
and a downstream Met-turn – features characteristic of metzincin
metalloproteases (McHugh et al., 2004; Gomis-Rüth, 2003).
Leishmanolysin (Gp63), the closest homolog of invadolysin, is
the founding member of the M8 family of metalloproteases (Gomis-
Rüth, 2003). Invadolysin, however, also has a conserved lipase
motif downstream of (but very near) the conserved metalloprotease
motif. Does invadolysin act as a protease, a lipase or both? No other
protein has been shown to have dual proteolytic and lipolytic
activity. Our earliest studies demonstrated increased levels of a
number of nuclear envelope proteins in Drosophila larval extracts
and cleavage of lamin by invadolysin in an in vitro assay, suggesting
the presence of proteolytic activity (McHugh et al., 2004).
Invadolysin is also the only protease described as localising to
lipid droplets; shown by immunofluorescence as well as
biochemical fractionation of cells (Cobbe et al., 2009). We
showed that invadolysin localises to newly formed lipid droplets
in cultured cells following refeeding after serum starvation and
increases during adipogenesis of murine 3T3-L1 and human SGBS
cells, coincident with an increase in the lipid depot during adipocyte
differentiation (Chang et al., 2016). These studies thus point toward
a role for invadolysin in lipid metabolism and insulin signalling
(Chang et al., 2016; Cobbe et al., 2009).
Using transgenic Drosophila strains that overexpress wild-type,
protease- or lipase-dead forms of invadolysin, we examined the role
of these conserved motifs on lipid and glycogen accumulation. Flies
overexpressing wild-type or lipase-dead forms of invadolysin
achieved significantly higher triglyceride to protein ratios
compared to control animals, suggesting the lipase motif is not
important in this context. On the other hand, Drosophila
overexpressing the protease-dead invadolysin transgene were
unable to accumulate excess triglyceride, and the triglyceride to
protein ratio remained similar to control animals. These results
strongly suggest that the protease motif of invadolysin is important
for a role in lipid accumulation, though mechanistically how is not
clear from these experiments. This is the first direct evidence that
proteolytic activity is necessary for invadolysin’s function.
While overexpression of the invadolysin transgenes had no
significant impact on the glycogen to protein ratio compared to
control animals, in a loss-of-function context, glycogen levels were
significantly reduced in invadolysin mutants (Chang et al., 2016).
Impaired insulin signalling in invadolysin mutants would be
predicted to affect glycogen accumulation, leading to the
observed lower glycogen to protein ratio in invadolysin mutants
(Chang et al., 2016). Taken together, our results strongly suggest a
role for invadolysin in normal physiology, potentially in an
extracellular, endocrine signalling context.
With the goal to understand the biosynthesis of invadolysin, we
examined the sequence for potential post-translational
modifications. Sequence analysis programmes highlighted an N-
terminal signal sequence, numerous N- and O-linked glycosylation
sites, and consensus for addition of a C-terminal GPI-anchor. These
motifs suggest that variant 1 of invadolysin should be synthesised in
the endoplasmic reticulum, while variant 2 may be translated in the
cytosol. We thus examined both invertebrate hemolymph and
vertebrate blood for the presence of invadolysin. Adult Drosophila
Fig. 2. Proteolytic activity of invadolysin is required for its role in lipid
accumulation. (A) Schematic of wild-type, protease- and lipase-dead
versions of invadolysin highlighting the sites of the introduced mutations.
(B) Schematic of endogenous and transgenic invadolysin RNA illustrating the
primers that selectively amplify transgenic invadolysin. (C) RT-PCR showed
that the invadolysin transgene can be expressed using a ubiquitous tubulin-
Gal4 driver. (D) Sequencing results from analysis of PCR amplicons
confirmed that the transgenic flies have the induced mutations in the
invadolysin transgenes. (E) Triglyceride:protein ratio in flies overexpressing
either wild-type or mutant versions of invadolysin. Flies overexpressing
wild-type and the lipase-dead form of invadolysin had a significantly higher
triglyceride:protein ratio than control flies, while flies overexpressing the
protease-dead form of invadolysin failed to accumulate excess lipids,
highlighting the importance of the metalloprotease motif in lipid accumulation.
(F) Glycogen:protein ratio in flies overexpressing either wild-type or mutant
versions of invadolysin. There was no significant difference in glycogen:
protein ratio comparing the transgenic invadolysin strains with the control flies
suggesting neither proteolytic nor lipolytic activity were directly important for
glycogen accumulation. *P-value 0.0201, **P-value 0.0027.
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Fig. 3. A form of invadolysin is secreted into Drosophila haemolymph. (A) Schematic of Drosophila invadolysin with the G4100 antibody epitope highlighted.
(B,C) Hemolymph fractions from male and female adult Drosophila, respectively. A secreted form of invadolysin can be detected in the soluble hemolymph fraction
of both males and females. (D,E) Invadolysin in gonads and soluble hemolymph in male and female Drosophila, respectively, show similar molecular weight
forms. (F,G) Analysis of the effects of protein transport inhibitors on secretion of invadolysin in male and female Drosophila, respectively. Feeding flies either
Tunicamycin or Brefeldin A/Monensin resulted in decreased invadolysin in adult male plasma, but did not affect the level of invadolysin in adult female plasma.
7
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Fig. 4. Secreted form of invadolysin is conserved in higher vertebrates. (A) Schematic of alternative variants of human invadolysin. Epitopes against
which antibodies to invadolysin have been generated are highlighted. (B,C) Mouse blood fractions probed with R2192 and G6456 antibodies identified a
secreted form of invadolysin in serum and plasma fractions of mouse blood. R2192 further detected a 66 kDa form of invadolysin that was enriched in the
cellular fraction of blood. (D,E) Secreted invadolysin was further identified in rat and pig plasma. (F,G) Human plasma probed using G3646 and G6456
antibodies identified a secreted form of invadolysin. (H) Human plasma probed with G6456 anti-invadolysin antibody after abundant proteins have been
removed by chromatography. After removal of abundant plasma proteins, the invadolysin signal becomes more prominent and better resolved.
8
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Fig. 5. Secreted invadolysin is N- and O-glycosylated. (A) PEG 6000 precipitation of human plasma to enrich for invadolysin using PEG concentrations
ranging from 4–10%. Aliquots of supernatant and pellet fractions were probed with the G3646 antibody. (B,C) Analysis of post-translational modification of
invadolysin in PEG-precipitated supernatant and pellet, respectively, after 8% PEG 6000 precipitation of human plasma. Samples were treated with calf
intestinal phosphatase (CIP; phosphorylation), PI-PLC (GPI-anchor), PNGase F (N-linked glycosylation) and O-Glycosylase (O-linked glycosylation).
Enzymatic treatment and subsequent immunoblotting demonstrated that invadolysin in human plasma is N- and O-glycosylated, but likely not GPI-linked.
The prominent bands at ∼35 and ∼150 kDa (red asterisks) in the PNGase F and O-Glycosidase lanes represent the added enzymes, respectively. The
molecular weight of CIP is 69 kDa, which explains the higher level of protein observed around the 64 kDa marker in the second lane.
9
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hemolymph contained invadolysin, but unexpectedly male and
female forms differed substantially in molecular weight. Treatment
of Drosophila with drugs that inhibit protein secretion had a
dramatic effect on the invadolysin level in adult male but not in
female hemolymph. This observation suggests the testable
hypothesis of alternative biosynthetic pathways in males versus
females. Whether the expression of sexually dimorphic forms in
adult flies is a mere consequence of differentiation, or an active
participant in sexual dimorphism remains to be resolved.
Subsequently, we examined plasma from higher vertebrates such
as mouse, rat, pig and human to ask whether the secretion of
invadolysin was conserved in higher vertebrates. Invadolysin was
detected in plasma of all species analysed to date, although we have
not yet found any indication for the existence of sexually dimorphic
forms in higher organisms. We also identified a distinct form of
invadolysin in the cellular fraction of mouse blood. Whether this
form is present in particular blood cells is currently under
investigation. We determined that human plasma invadolysin was
both N- and O-glycosylated, but likely not GPI-linked. Post-
translational modification may be important for the interaction with
specific binding partners such as regulators or substrates, leading to
the modulation of invadolysin’s activity.
What cells or tissues are responsible for the secretion of
invadolysin in hemolymph or plasma is currently unclear.
Immunoblotting of Drosophila male and female gonads for
invadolysin identified invadolysin variants similar to those
present in hemolymph, suggesting gonads might be responsible
for invadolysin production and secretion (or that they take up
invadolysin from hemolymph). Many vertebrate plasma proteins are
synthesised in the liver, but whether this is true for invadolysin is
unknown.
Leishmanolysin/GP63 has been shown to exist in three forms:
intracellularly, membrane-anchored at the surface of Leishmania,
and as a secreted form (Yao et al., 2007). Leishmanolysin has also
been detected in the exosome-enriched extracellular vesicular
fraction. Intriguingly, zymography of exosome fractions from
wild-type and leishmanolysin-knockout L. major strains showed
that knockout of leishmanolysin diminished exosome-associated
proteolytic activity (Hassani et al., 2014). We examined fractionated
human plasma to determine whether invadolysin is also present in
the extracellular vesicular fraction. While clearly present in the
purified extracellular vesicle fraction (containing exosomes and
microvesicles), invadolysin could also be detected in the other
fractions of human plasma. We therefore postulate that invadolysin,
like leishmanolysin, is present in different locations, participating in
diverse functions.
The soluble fraction of blood is an extraordinarily complex and
dynamic assembly of diverse components that plays a wide variety
of roles in regulating signal transduction, cell proliferation,
differentiation, migration and apoptosis in metazoa (György et al.,
2011). Our discovery of invadolysin in readily accessible vertebrate
plasma opens the doors to biochemical and physiological analyses
not particularly tractable with the limited quantities of invertebrate
hemolymph obtainable. Identification of proteins interacting with
invadolysin will help in understanding the network of invadolysin’s
mechanism of action. Is invadolysin active in vertebrate blood? If
so, what are its substrates, and how is its activity regulated?
Examination of human plasma from control and disease states will
shed light on whether invadolysin acts as a biomarker for any
pathophysiological states. We anticipate that the study of
invadolysin in the extracellular milieu will continue to yield novel
insights into this conserved metalloprotease.
MATERIALS AND METHODS
In silico and statistical analysis
Amino acid sequences were obtained from the Ensembl genome browser
and ClustalX was used for multiple protein sequence alignments. Jalview
was used to annotate and highlight key elements of the protein sequence and
generate schematics. The programmes used for in silico analysis of amino
acid sequence features are described in the text. GraphPad Prism 5 was used
to carry out statistical analysis of data and generate graphs.
Drosophila experiments
All fly stocks were maintained at 25°C on a standard medium unless
otherwise stated. Fly stocks used in this study were: Canton S (wild type),
y w P{nos-phiC31}X; attp40, y w-; attp40{UASinvwt}/CyO, y w-;
attp40{UASinvE258A}/CyO, y w-; attp40{UASinvS266A}/CyO and TubP-
Gal4/CyO. For inhibition of the protein secretory pathway, adult flies were
fed a cocktail of either 10.6 μM Brefeldin A /2 μM Monensin (Thermo
Fisher Scientific) or 60 μM Tunicamycin (Sigma-Aldrich) in 0.15 M
sucrose for 7 h at 25°C.
Cloning, mutagenesis and generation of transgenics
For generation of transgenic invadolysin constructs, invadolysin cDNA
(RH66426) was obtained from the Drosophila Genomics Resource Center,
Indiana University. Transgenic constructs used for generating transgenic
flies were made using Thermo Fisher Scientific’s gateway cloning
technology. Entry clone was obtained from Invitrogen (now Thermo
Fisher Scientific). Expression clones were obtained from the laboratory of
Brian McCabe, Columbia University (Wang et al., 2012). Mutant versions
of the invadolysin transgene were generated by site-directed mutagenesis
(Carter, 1986). Primers designed for the site-directed mutagenesis reaction
were obtained from Sigma-Aldrich and were HPLC-purified. Transgenic
constructs were injected into the posterior region of Drosophila embryos
(where pole cells would form) of a y, w, P{nos-phiC31}X; attP40
Drosophila strain. The transgenes were inserted on the second chromosome.
Fig. 6. Ultracentrifugation of human plasma to enrich extracellular
vesicles and immunoblotting for invadolysin identified invadolysin in
the extracellular vesicular fraction. (A) Flotillin-1 is utilised as a positive
marker for the extracellular vesicle fraction. (B,C) Probing of centrifugation
fractions with invadolysin antibodies G3646 and G6456.
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Total RNA extraction and RT-PCR
Total RNA from Drosophila larvae was extracted using the RNeasy Mini
Kit (Qiagen) following the manufacturer’s instructions. Total RNA was
treated with DNase (Roche) to degrade any genomic DNA contamination.
RT-PCR reactions were performed using Superscript III reverse
transcriptase (Life Technologies). For specific amplification of transgenic
invadolysin, PCR was performed using invadolysin primers (Sigma-
Aldrich) designed to selectively amplify the invadolysin transgene.
Amplification of transgenic invadolysin RNA was performed using
GoTaq Green Master Mix (Promega).
Triglyceride, glycogen and protein assay
The samples for triglyceride, glycogen and protein assays were prepared as
described previously (Bolukbasi et al., 2012). Four adult flies (separated by
gender) were homogenised in 400 µl PBS+0.05% Tween-20. Homogenates
were heat-inactivated at 65°C for 5 min. Samples were centrifuged at
1200×g for 1 min and the supernatant was transferred to a new tube. The
supernatant was centrifuged again at 600×g for 3 min. An aliquot of the
sample was used for triglyceride, glycogen and protein assays. Triglyceride
and glycogen were quantified using BioVision’s Triglyceride/Glycogen
Quantification Colorimetric/Fluorometric Kit, and protein was quantified
using a Bradford assay kit (Sigma-Aldrich) following the manufacturers’
instructions.
Hemolymph extraction
Hemolymph was extracted from adult flies in EBR solution (130 mMNaCl,
4.7 mM KCl, 1.9 mM CaCl2 and 10 mM HEPES, pH 6.9) containing
20 mMEDTA (Karlsson et al., 2004). Each sample was prepared by pooling
hemolymph from 15 adult male or female flies. For collecting hemolymph,
the thorax of the fly was punctured and flies were placed in a 0.5 ml tube
with a hole in the bottom. The 0.5 ml tube was placed in a 1.5 ml Eppendorf
tube containing the 100 µl EBR solution. The tubes were spun for 20 s
at 300×g to collect hemolymph. Hemolymph was separated into plasma and
cellular fractions by centrifugation for 10 min at 300×g (Karlsson et al.,
2004).
Clean-up of human plasma samples
The Pierce Abundant Protein Depletion Spin Columns (Cat. No.: 85164)
from Thermo Fisher Scientific were utilised to remove the 12 most abundant
proteins from human plasma. The proteins removed include: α1-Acid
Glycoprotein (42 kDa), α1-Antitrypsin (54 kDa), α2-Macroglubulin
(85 kDa), Albumin (66.5 kDa), Apolipoprotein A-I (28.3 kDa),
Apolipoprotein A-II (17.4 kDa), Fibrinogen (340 kDa), Haptoglobin (18,
45 kDa), IgA (55, 23 kDa), IgG (50, 23 kDa), IgM (65, 23 kDa), and
Transferrin (80 kDa).
SDS-PAGE and immunoblotting
Protein sample preparation and immunoblotting was performed as
previously described (Cobbe et al., 2009). Nitrocellulose membranes were
probed with primary antibodies listed in the text, and described in previous
publications. The Flotillin-1 polyclonal antibody (PA5-19713) was
purchased from Thermo Fisher Scientific. Horseradish peroxidase-
conjugated secondary antibodies were used, and the immune-signal was
detected by ECL (GE Healthcare) with Lumi-Film Chemiluminescent
detection film (Roche). All invadolysin antibodies have been previously
published by our laboratory and described in the publications from our
laboratory. While we do not yet fully understand the specific biosynthetic
processing of invadolysin, we are not unable to unambiguously identify all
bands observed by immunoblotting.
Enzymatic treatment of plasma
In silico predictions for post-translational modification of invadolysin were
tested biochemically by enzymatic treatment to remove the predicted
modifications. Analysis was done by immunoblotting to observe shifts in
protein migration. Human plasma was treated with CIP (Calf Intestinal
Alkaline Phosphatase) (NEB; M0290S), PI-PLC (Thermo Fisher
Scientific), PNGase F (NEB; P0704S) or a mixture of O-Glycosidase
(NEB; P0733S) and α2-3,6,8 Neuraminidase (NEB; P0720S) following the
manufacturer’s instructions. For PI-PLC (Thermo Fisher Scientific), 0.1
enzyme unit was used to treat 10 μg of whole plasma (10 μl).
Extracellular vesicular fractionation
Freshly collected blood in heparin tubes was centrifuged at 2000×g for
30 min to obtain plasma. Plasma was then diluted with an equal volume of
PBS (136.9 mM NaCl, 2.67 mM KCl, 8.10 mM Na2HPO4, 1.47 mM
KH2PO4, pH 7.4). Fractionation was then performed at 4°C. Plasma was
centrifuged at 13,000×g for 45 min in Eppendorf tubes. Supernatant was
collected and ultra-centrifuged at 110,000×g for 70 min. The supernatant
was discarded and the pellet was resuspended in PBS. Extracellular vesicles
were pelleted by ultra-centrifugation at 110,000×g for 70 min. The pellet
containing the extracellular vesicles was resuspended in PBS for subsequent
analysis or stored at −80°C.
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